CAS: 66909-35-1; 6-Chloro-4-Methylnicotinonitrile

该化合物是有机合成的多用途中间体,具有极好的稳定性和反应性. 它的独特结构促进了各种转变,使其成为制药和农用化学物质的宝贵基石. 化合物的高度纯度和连续的批量到批量的连贯性确保了化学反应的可靠性能.

英文名称6-Chloro-4-Methylnicotinonitrile
中文名称2-氯-4-甲基吡啶-5-甲腈
IUPAC名称6-chloro-4-methylnicotinonitrile
其它别名2 - 氯-4 - 甲基-5 - 氰基吡啶; 6-Chloro-4-Methyl-Pyridine-3-Carbonitrile
CAS编号66909-35-1
MFCD编号:MFCD17214204
EINECS号:688-388-3
分子式:C7H5ClN2
分子量:152.58
产品CID: 1650704
产品分类有机原料→分子砌块→芳杂环类化合物→吡啶类化合物

相似结构搜索
InChIKey: DWLWCFHFMYBZKE-UHFFFAOYSA-N
InChI=1S/C7H5ClN2/c1-5-2-7(8)10-4-6(5)3-9/h2,4H,1H3…
计算化学: 氢键受体数2.0氢键供体数0.0可旋转键数0.0

相似化合物

503555-50-8 884495-38-9 875-35-4

MSDS等安全信息

GHS象形图
GHS符号GHS07;
注释: Exclamation mark
危险类别急性毒性类别4(吸入)
急性毒性类别4(经皮)
急性毒性类别4(经口)
特定目标器官毒性 - 单次接触类别3
皮肤腐蚀/刺激类别2
严重眼刺激类别2A
严重眼刺激类别2
警示词Warning(警告)
危险描述H332 |吸入有害.
H312 |皮肤接触有害.
H302 |吞咽有害.
H335 |可能引起呼吸道刺激.
H315 |造成皮肤刺激.
H319 |造成严重眼刺激.
防范说明P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
危险品标志Xn

欧盟法规

ECHA物质C&L通报

上下游产品

2-amino-5-bromo-4-methylpyridine 2-amino-5-cyano-4-methylpyridine

合成工艺路线路线简述

海关参考信息

2933310010-吡啶
2926909090-其他腈基化合物
2939800000-其他生物碱
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-2024383853-A1
优先权日:2021-09-28
标题:Oximes and their use in treatment of gba-related diseases
发明人：NEVE SÃ˜REN; BROWN WILLIAM DALBY; THIRSTRUP KENNETH
权利人:ZEVRA DENMARK AS
摘要:The present invention relates to oximes, their synthesis, and their use for increasing GBA activity and/or levels as well as treatment of GBA-related diseases, such as Parkinson's disease.

专利号:US-12358903-B2
优先权日:2016-06-13
标题 :FXR (NR1H4) modulating compounds
发明人：BLOMGREN PETER A; CURRIE KEVIN S; FARAND JULIE; GEGE CHRISTIAN; KROPF JEFFREY E; XU JIANJUN
权利人:GILEAD SCIENCES INC
摘要:The present disclosure relates generally to compounds which bind to the NR1H4 receptor (FXR) and act as agonists of FXR. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and to a process for the synthesis of said compounds.